MercadoLibre and Chipotle: 2 Consumer Names With Serious Pricing Power​

MercadoLibre is widening its Latin American lead by increasing e-commerce monetization and fintech adoption: e-commerce take rate rose to 25.2% in Q3 2025 (from 18.4% two years earlier), unique active buyers grew 26% YoY, fintech monthly active buyers rose 29% YoY to 72 million, and analysts forecast ~32% annual earnings growth. Chipotle shows durable pricing power—menu prices up 5.2% (2023), 2.9% (2024) and 2.3% YTD through Q3 2025—delivering resilient same-store sales historically (>7%) though most recent comps were +0.3% with total revenue +7% YoY; the chain has ~4,000 stores with a long-term target of 7,000 and trades near ~33x forward earnings.

Analysis

Market structure: MercadoLibre (MELI) and Chipotle (CMG) are clear beneficiaries — MELI from a rising e‑commerce + fintech take rate (18.4% → 25.2% in two years) and user growth (unique buyers +26%, fintech MAUs +29%), CMG from persistent menu pricing power (prices +5.2% in 2023, +2.9% in 2024). Direct losers are small local marketplaces, legacy banks (card/credit volume migration), and low-margin retailers unable to match logistics/loyalty investments. Rising take rates imply structurally higher revenue per GMV, shifting share to platform incumbents and raising entry costs for rivals.

Risks: Material tail risks include LATAM regulatory interventions (data/localization, interchange caps), sharp BRL/ARS depreciation (>10% quarter), and fintech credit losses if unemployment rises — each could wipe out >20–30% of near‑term upside. Near term (days–weeks) expect earnings/FX-driven volatility; medium term (3–12 months) monitor MAU and take‑rate trajectory; long term (2–5 years) depends on sustained cross‑sell and logistics scale. Hidden dependency: MELI’s margin expansion presumes low incremental credit loss rates and logistics unit economics — if those deteriorate the take‑rate story unwinds.

Trade implications: Establish a concentrated but hedged exposure to MELI (see decisions). Use pair trades (long MELI, short broad EM ETF like EEM) to isolate company upside from EM beta and buy 9–12 month call spreads to capture product/earnings catalysts while limiting premium. For CMG, prefer tactical option exposure or a small accumulation on confirmed same‑store sales rebound (>+3% YoY in two consecutive quarters) rather than full equity size today.

Contrarian angles: Consensus understates currency/regulatory risk for MELI — pricing power can be reversed if governments cap fees or force interchange reductions. Conversely, investors may be under‑estimating CMG’s room to raise prices (management says still 20–30% below peers), implying asymmetric upside if traffic stabilizes. Historical parallel: MELI resembles early Amazon in network effects but with higher sovereign/FX risk; unintended consequence — aggressive monetization could slow GMV growth and prompt seller churn, measurable via a >5ppt decline in GMV growth over two quarters.

Key Decisions for Investors

• Establish a 3% portfolio long position in MELI within 30 trading days, size by NAV; hedge currency risk by buying a 3‑month BRL put protecting a >10% FX move (or equivalent forward) sized to cover 50% of equity notional. Exit/trim if quarterly unique active buyers growth falls below +10% YoY or if EPS misses consensus by >10% two quarters in a row.
• If avoiding spot equity, implement a 9–12 month MELI call spread (buy ATM LEAP, sell +25% OTM) sized to 1–1.5% portfolio risk; target net return ≥25% if stock rallies 20–30%, max loss = premium. Close or roll if implied volatility rises >30% above historical or if take‑rate growth stalls sequentially.
• Establish a tactical 1% long position in CMG only on confirmation of same‑store sales improvement: add if two consecutive quarters show SSS >+3% YoY; alternatively buy 6‑9 month ATM calls sized to 0.75% portfolio to play asymmetric upside. Trim if same‑store sales drop below 0% for two consecutive quarters or if management signals price elasticity issues.
• Implement a relative‑value hedge: long MELI (3%) vs short EEM (1.5%) to neutralize broad EM beta; rebalance quarterly and unwind if MELI underperforms EEM by >15% over any 60‑day window or if EM macro indicators (Brazil CPI or sovereign spreads) widen >150bp.